Handbook of Evidence-Based Critical CareSpringer Science & Business Media, 2001 - 535 páginas This is the first bedside pocket reference ever published in evidence-based Critical Care Medicine. It is designed to act as a complement to and precede the forthcoming, larger shelf reference by Zaloga and Marik on Evidence-Based Critical Care Medicine. Its purpose will be to provide easy access to clinical data which is crucial in therapeutic decision-making. This approach will enable the clinician to quickly review the information which will support or refute an intervention and choose the most appropriate, cost-effective treatment. The analysis of treatment strategies will be presented by organ-systems, and there will be miscellaneous ICU topics (eg: severity of illness scoring systems, nutrition, toxicology, infection) covered. The selection of these topics will be based on the most frequently found and difficult to solve problems in ICU patient management. |
Índice
I | 1 |
II | 5 |
III | 13 |
VI | 21 |
VII | 27 |
VIII | 35 |
IX | 43 |
X | 47 |
XLVIII | 273 |
XLIX | 281 |
L | 285 |
LI | 291 |
LII | 299 |
LIII | 311 |
LIV | 317 |
LV | 321 |
XI | 55 |
XII | 61 |
XIII | 67 |
XIV | 75 |
XV | 87 |
XVI | 95 |
XVII | 101 |
XIX | 103 |
XX | 109 |
XXIII | 123 |
XXVII | 141 |
XXIX | 155 |
XXX | 163 |
XXXI | 175 |
XXXII | 189 |
XXXIII | 203 |
XXXIV | 215 |
XXXV | 221 |
XXXVIII | 229 |
XXXIX | 233 |
XLI | 241 |
XLII | 251 |
XLIII | 263 |
LVII | 331 |
LVIII | 339 |
LX | 347 |
LXI | 357 |
LXII | 367 |
LXIII | 379 |
LXIV | 385 |
LXV | 393 |
LXVI | 399 |
LXVII | 413 |
LXVIII | 421 |
LXIX | 433 |
LXX | 439 |
LXXI | 443 |
LXXII | 449 |
LXXIII | 457 |
LXXIV | 465 |
LXXV | 471 |
LXXVIII | 479 |
LXXIX | 501 |
LXXX | 505 |
507 | |
Otras ediciones - Ver todo
Términos y frases comunes
ACE inhibitors acidosis adrenal insufficiency agents airway amiodarone angina antibiotics APACHE II arrhythmias aspiration associated atrial fibrillation beta-blockers bleeding blood pressure calcium cardiac output catheter cause cerebral chest chronic clinical complications Crit critically ill patients decreased demonstrated diagnosis digoxin disease dose drug dysfunction edema effects endotracheal tube Engl fever fibrillation fluid function gastric glucose heart failure hemodynamic hemorrhage heparin hepatic hyperglycemia hypertension hypocalcemia hyponatremia hypotension ICU patients increase infection infusion inhibitors initial injury insulin intravascular volume intravenous intubation ischemia ischemic left ventricular levels liver Lorazepam lung mechanical ventilation mEq/L metabolic mg/dL mg/kg monitoring mortality myocardial infarction normal occur outcome oxygen PAOP patients with acute patients with severe PEEP perfusion Phenytoin plasma pneumonia propofol pulmonary artery randomized recommended reduce renal failure respiratory result resuscitation risk sedation seizures sepsis septic serum stroke studies syndrome systemic tachycardia therapy tion tissue toxicity treatment trial venous